Home ›
Trademark Categories ›
Pharmaceuticals ›
2013 ›
NU ›
NUVIQ
Trademark search for:
NUVIQ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2013-05-15 — Application filed
2013-07-18 — Sn assigned for sect 66a appl from ib
2013-07-19 — Application filed
2013-07-23 — Application filed
2013-08-23 — New representative at ib received
2013-09-03 — Assigned to examiner
2013-09-09 — Final disposition recorded
2013-09-10 — Office action issued
2013-09-10 — Office action issued
2013-09-10 — Office action issued
2013-09-30 — Office action issued
2013-10-28 — Teas/email correspondence entered
2013-10-28 — Office action issued
2013-10-28 — Correspondence received in law office
2013-10-29 — Approved for pub - principal register
2013-11-18 — Assigned to lie
2013-11-18 — Law office publication review completed
2013-12-04 — Notification of possible opposition sent to ib
2013-12-04 — Notification of notice of publication e-mailed
2013-12-04 — Notice of start of opposition period created, to be sent to ib
2013-12-24 — Published for opposition
2013-12-24 — Official gazette publication confirmation e-mailed
2013-12-24 — Notification processed by ib
2014-03-11 — Registered-principal register
2014-06-11 — Final disposition recorded
2014-07-15 — Final disposition recorded
2014-07-15 — Final disposition recorded
2014-07-31 — Final disposition recorded
2016-08-11 — New representative at ib received
2016-08-18 — New representative at ib received
2019-03-11 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2021-02-26 — Cancelled section 71
2021-10-26 — Total invalidation of reg ext protection created
2022-02-19 — Total invalidation of reg ext protection sent to ib
2022-02-19 — Invalidation processed
2022-03-20 — Total invalidation processed by the ib
2023-05-14 — Final status recorded
2023-12-10 — Death of international registration
2023-12-10 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Octapharma AG
Octapharma AG
Octapharma AG
Correspondent
Lawrence E. Abelman Abelman Frayne & Schwab
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
